IMMUNEERING CORP - CLASS A (IMRX)
US45254E1073 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to IMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.55. This target is 821.86% above the current price.
IMRX was analyzed by 14 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about IMRX.
In the previous month the buy percentage consensus was at a similar level.
IMRX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-04-02 | Mizuho | Maintains | Buy -> Buy |
| 2024-03-15 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2024-03-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-15 | Needham | Maintains | Buy -> Buy |
| 2024-03-15 | Jefferies | Downgrade | Buy -> Hold |
| 2024-03-14 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-03-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-05 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-04 | Needham | Reiterate | Buy -> Buy |
| 2024-02-01 | Needham | Reiterate | Buy -> Buy |
| 2023-12-01 | Needham | Initiate | Buy |
| 2023-08-08 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-07 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-04-19 | Chardan Capital | Maintains | Buy |
| 2023-04-19 | Mizuho | Upgrade | Neutral -> Buy |
| 2023-04-19 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-04-18 | Chardan Capital | Maintains | Buy |
| 2023-03-30 | Mizuho | Initiate | Neutral |
| 2023-03-07 | Chardan Capital | Reiterate | Buy |
| 2023-02-03 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-08 | Chardan Capital | Initiate | Buy |
| 2022-01-07 | Piper Sandler | Initiate | Overweight |
| 2021-08-24 | Guggenheim | Initiate | Buy |
| 2021-08-24 | Cowen & Co. | Initiate | Outperform |
| 2021-08-24 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-08-24 | Jefferies | Initiate | Buy |